BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 15, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Progenics, Salix sales and marketing update

Progenics disclosed in its 2Q11 earnings conference call that Salix has secured a commercialization deal for Relistor methylnaltrexone in Australia and some related Asian territories. Additionally, Progenics said an EU...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >